Histopathological and Molecular Characteristics of Pediatric Adrenocortical Tumors: where Do we Stand?

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Endocrine pathology

• Publication date

  2026-02-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12022-026-09905-3PMID 41712100PMCID PMC12920729
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma.

  2024cited by this paper
• Precocious puberty and other endocrine disorders during mitotane treatment for paediatric adrenocortical carcinoma – case series and literature review

  2024cited by this paper
• Molecular and Clinical Features of Adrenocortical Tumors in Beckwith–Wiedemann Spectrum

  2024cited by this paper
• Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma

  2024cited by this paper
• Prognostic value of the Weiss and Wieneke(AFIP) scoring systems in pediatric ACC.

  2023cited by this paper
• Diagnostic Utility of a Modified Reticulin Algorithm in Pediatric Adrenocortical Neoplasms

  2023cited by this paper
• Pediatric adrenocortical carcinoma: clinical features and application of neoadjuvant chemotherapy

  2023cited by this paper
• Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems

  2023cited by this paper
• Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma

  2023cited by this paper
• ATRX, a guardian of chromatin.

  2023cited by this paper
• Engineering functional 3-dimensional patient-derived endocrine organoids for broad multiplatform applications

  2022cited by this paper
• DNA methylation is a comprehensive marker for pediatric adrenocortical tumors.

  2022cited by this paper
• Identification of potential core genes and miRNAs in pediatric ACC via bioinformatics analysis.

  2022cited by this paper
• Histopathological Criteria for Paediatric Adrenocortical Carcinoma

  2022cited by this paper
• Vitamin D receptor hypermethylation as a biomarker for pediatric adrenocortical tumors.

  2022cited by this paper
• Overview of the 2022 WHO Classification of Adrenal Cortical Tumors

  2022cited by this paper
• MicroRNA expression profile predicts prognosis of pediatric adrenocortical tumors

  2021cited by this paper
• Clinical Impact of Pathological Features Including the Ki-67 Labeling Index on Diagnosis and Prognosis of Adult and Pediatric Adrenocortical Tumors

  2021influential reference
• The Role of Immunohistochemical Markers for the Diagnosis and Prognosis of Adrenocortical Neoplasms

  2021influential reference
• Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol

  2021influential reference
• Survival characteristics of localized pediatric adrenocortical carcinoma managed with adenectomy: A national cancer center database analysis.

  2021cited by this paper
• Lamin B1 sequesters 53BP1 to control its recruitment to DNA damage

  2021cited by this paper
• PD-1 Blockade in Advanced Adrenocortical Carcinoma.

  2020cited by this paper
• Clinical, Genetic, and Prognostic Features of Adrenocortical Tumors in Children: A 10-Year Single-Center Experience

  2020cited by this paper
• Frequency of the TP53 p.R337H mutation in a Brazilian cohort of pediatric patients with solid tumors

  2020cited by this paper
• TP53 p.Arg337His geographic distribution correlates with adrenocortical tumor occurrence

  2020cited by this paper
• High Prevalence of Alterations in DNA Mismatch Repair Genes of Lynch Syndrome in Pediatric Patients with Adrenocortical Tumors Carrying a Germline Mutation on TP53

  2020cited by this paper
• Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma

  2019cited by this paper
• DNA Methylation Profiling Reveals Prognostically Significant Groups in Pediatric Adrenocortical Tumors: A Report From the International Pediatric Adrenocortical Tumor Registry.

  2019cited by this paper
• Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial.

  2019cited by this paper
• Childhood adrenocortical tumor

  2019cited by this paper
• Diseases Predisposing to Adrenocortical Malignancy (Li-Fraumeni Syndrome, Beckwith-Wiedemann Syndrome, and Carney Complex).

  2019cited by this paper
• The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity

  2018cited by this paper
• Adrenocortical Carcinoma in Children: A Clinicopathological Analysis of 41 Patients at the Mayo Clinic from 1950 to 2017

  2018cited by this paper
• Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review

  2018influential reference
• The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study

  2018influential reference
• Nutlin‐3a as a novel anticancer agent for adrenocortical carcinoma with CTNNB1 mutation

  2018cited by this paper
• Pathological prognostication of paediatric adrenocortical tumours: Is a gold standard emerging?

  2018cited by this paper
• Pediatric adrenocortical neoplasms: immunohistochemical expression of p57 identifies loss of heterozygosity and abnormal imprinting of the 11p15.5

  2017cited by this paper
• Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors

  2017cited by this paper
• Inherited TP53 Mutations and the Li-Fraumeni Syndrome.

  2017cited by this paper
• Outcome and prognostic factors in high‐risk childhood adrenocortical carcinomas: A report from the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT)

  2017cited by this paper
• Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.

  2017cited by this paper
• Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

  2016cited by this paper
• Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?

  2016influential reference
• An International Ki67 Reproducibility Study in Adrenal Cortical Carcinoma

  2016cited by this paper
• Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study

  2016cited by this paper
• Factors associated with survival in pediatric adrenocortical carcinoma: An analysis of the National Cancer Data Base (NCDB).

  2016cited by this paper
• Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

  2016cited by this paper
• Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.

  2015cited by this paper
• IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.

  2015cited by this paper
• Development of adrenal cortex zonation.

  2015cited by this paper
• Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.

  2015cited by this paper
• Genomic landscape of pediatric adrenocortical tumors

  2015influential reference
• Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study.

  2015cited by this paper
• Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas.

  2015cited by this paper
• Low expression of HLA‐DRA, HLA‐DPA1, and HLA‐DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT)

  2014cited by this paper
• Amplification of the Insulin-Like Growth Factor 1 Receptor Gene Is a Rare Event in Adrenocortical Adenocarcinomas: Searching for Potential Mechanisms of Overexpression

  2014cited by this paper
• Integrated genomic characterization of adrenocortical carcinoma

  2014cited by this paper
• Spindle assembly checkpoint gene expression in childhood adrenocortical tumors (ACT): Overexpression of Aurora kinases A and B is associated with a poor prognosis

  2013cited by this paper
• Adrenocortical carcinoma is a lynch syndrome-associated cancer.

  2013cited by this paper
• Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent

  2013cited by this paper
• Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.

  2013cited by this paper
• Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study.

  2013influential reference
• SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.

  2012cited by this paper
• Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors

  2012cited by this paper
• Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer

  2011cited by this paper
• Wnt/beta-catenin pathway deregulation in childhood adrenocortical tumors.

  2011cited by this paper
• Beckwith–Wiedemann syndrome

  2010cited by this paper
• Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers.

  2010cited by this paper
• Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect

  2010cited by this paper
• Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification

  2009cited by this paper
• Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma

  2009cited by this paper
• Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.

  2008cited by this paper
• High frequency of loss of heterozygosity at 11p15 and IGF2 overexpression are not related to clinical outcome in childhood adrenocortical tumors positive for the R337H TP53 mutation.

  2008cited by this paper
• Gene expression profiling of childhood adrenocortical tumors.

  2007cited by this paper
• The role of the IGF system in cancer growth and metastasis: overview and recent insights.

  2007cited by this paper
• Adrenocortical carcinoma

  2006cited by this paper
• Adrenocortical Oncocytic Tumors: Report of 10 Cases and Review of the Literature

  2004cited by this paper
• Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors.

  2004cited by this paper
• Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry.

  2004influential reference
• Adrenocortical carcinoma: diagnosis, evaluation and treatment.

  2003cited by this paper
• Adrenal Cortical Neoplasms in the Pediatric Population: A Clinicopathologic and Immunophenotypic Analysis of 83 Patients

  2003cited by this paper
• Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.

  2003influential reference
• A Clinicopathologic and Immunohistochemical Study of 49 Adrenocortical Tumors

  2002cited by this paper
• An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

  2002cited by this paper
• An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

  2001cited by this paper
• Adrenocortical carcinoma: clinical and laboratory observations.

  2000cited by this paper
• Childhood adrenocortical tumors.

  1997cited by this paper
• Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.

  1996cited by this paper
• Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.

  1990cited by this paper
• Pathologic Features of Prognostic Significance in Adrenocortical Carcinoma

  1989cited by this paper
• Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors

  1984cited by this paper

• No citing papers are available for this paper.